http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2500302-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_279cf3c9c0c8b0b077bba1fb8d10d744
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405
filingDate 1981-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d144b20efc2f58bd272f7f218ad1c54
publicationDate 1982-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2500302-A1
titleOfInvention NEW PHARMACEUTICAL COMPOSITIONS OF INDOMETACIN
abstract THE SUBJECT OF THE INVENTION IS NEW PHARMACEUTICAL COMPOSITIONS INTENDED TO BE ADMINISTERED ORALLY. THESE COMPOSITIONS ASSOCIATE INDOMETACIN WITH AN EXCIPIENT OF THE PASTE, OIL OR LIQUID TYPE CONTAINING ONE OR MORE LIPIDS AND OR POLYETHEROXIDES, WHERE APPLICABLE HYDROLYSES AND OR MIXED COMPONENTS OF LIPIDS AND POLYETHEROXIDES, WHERE APPROPRIATE, AND THEREFORE EXCEPTIONALLY PHOXYTICALLY, HYDROXIALLY EXCEPTIONAL. APPLICATION TO THE MANUFACTURE OF SOFT CAPSULES OF INDOMETACIN.
priorityDate 1981-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2081436-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2372635-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-2102889-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453266603
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457231771
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6354
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417430547
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538474
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82170
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137319715
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3715
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483452
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID43834305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490943
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585166

Total number of triples: 39.